[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 50.16.113.179. Please contact the publisher to request reinstatement.
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
Purchase Options:
[Skip to Content Landing]

Year

Day

February 23, 2017
Viewpoint

For-Profit Medical Schools—A Flexnerian Legacy Upended

Abstract Full Text
free access
JAMA. Published online February 23, 2017. doi:10.1001/jama.2017.0920

This Viewpoint discusses the emergence of for-profit medical schools and the implications of the new business model for the physician workforce and the quality of medical education and practice.

History of The Joint Commission’s Pain StandardsLessons for Today’s Prescription Opioid Epidemic

Abstract Full Text
free access
JAMA. Published online February 23, 2017. doi:10.1001/jama.2017.0935

This Viewpoint discusses the history of The Joint Commission standards for pain management and lessons learned that might inform current efforts to address the prescription opioid epidemic and prevent unintended consequences of future similar standard-setting initiatives.

February 22, 2017
Viewpoint

Revamping the US Federal Common RuleModernizing Human Participant Research Regulations

Abstract Full Text
free access
JAMA. Published online February 22, 2017. doi:10.1001/jama.2017.1633

In this Viewpoint, Hodge and Gostin summarize the most important 2017 updates to the US Federal Policy for the Protection of Human Subjects.

Medical News & Perspectives

US Uterus Transplant Trials Under Way

Abstract Full Text
free access
JAMA. Published online February 22, 2017. doi:10.1001/jama.2016.20735

This Medical News article discusses recent advances in uterus transplants.

February 20, 2017
Viewpoint

The European Medicines Agency and Publication of Clinical Study ReportsA Challenge for the US FDA

Abstract Full Text
free access
JAMA. Published online February 20, 2017. doi:10.1001/jama.2017.0918

This Viewpoint argues that publication by the European Medicines Agency of clinical study reports as part of its approval process for commercial drugs sets a standard of transparency that could challenge the reputation of the US Food and Drug Administration as the international standard-bearer in drug and device approval.

Correction

Error in Text

Abstract Full Text
free access
JAMA. Published online February 20, 2017. doi:10.1001/jama.2017.1637
February 16, 2017
Viewpoint

Reforming Federal Public Health PowersResponding to National and Global Threats

Abstract Full Text
free access
JAMA. Published online February 16, 2017. doi:10.1001/jama.2017.1021

This Viewpoint highlights potential effects of recent finalized changes to the Public Health Service Act.

Postapproval Observational Studies of Non–Vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation

Abstract Full Text
free access
JAMA. Published online February 16, 2017. doi:10.1001/jama.2017.1152

This Viewpoint discusses use of non–vitamin K oral anticoagulants in treating atrial fibrillation.

February 15, 2017
Viewpoint

Medical Liability Reform in a New Political Environment

Abstract Full Text
free access
JAMA. Published online February 15, 2017. doi:10.1001/jama.2017.1405

This Viewpoint proposes newly conceivable federal policy options under a Republican president and Congress that may offer a more bipartisan and comprehensive approach to medical liability reform.

Medical News & Perspectives

Alzheimer Outlook Far From Bleak

Abstract Full Text
free access
JAMA. Published online February 15, 2017. doi:10.1001/jama.2017.0276

This Medical News story features an interview with 2 leading Alzheimer disease researchers discussing the disease’s pathogenesis and potential treatments.

February 13, 2017
Viewpoint

Acknowledging and Overcoming Nonreproducibility in Basic and Preclinical Research

Abstract Full Text
free access
JAMA. Published online February 13, 2017. doi:10.1001/jama.2017.0549

In this Viewpoint, Ioannidis discusses the problem of nonreproducibility in biomedical research and proposes implementing reproducibility assessments to improve research practices.

Implementing Primary Prevention for Peanut Allergy at a Population Level

Abstract Full Text
free access
JAMA. Published online February 13, 2017. doi:10.1001/jama.2017.0922

This Viewpoint summarizes the National Institute of Allergy and Infectious Diseases’ guideline for prevention of peanut allergies in US infants and argues that the complexity and narrow scope of the recommendations could prevent population-wide implementation and uptake.

February 9, 2017
Viewpoint

Addressing Physician BurnoutThe Way Forward

Abstract Full Text
free access
JAMA. Published online February 9, 2017. doi:10.1001/jama.2017.0076

This Viewpoint proposes changes at the national, state, organization, leader, and individual levels to address and prevent physician burnout.

February 8, 2017
Medical News & Perspectives

Amid Reports of Infant Deaths, FTC Cracks Down on Homeopathy While FDA Investigates

Abstract Full Text
free access
JAMA. Published online February 8, 2017. doi:10.1001/jama.2016.19090

This Medical News article discusses adverse event reports about homeopathic teething products.

February 6, 2017
Viewpoint

Step Therapy—Clinical Algorithms, Legislation, and Optimal Prescribing

Abstract Full Text
free access
JAMA. Published online February 6, 2017. doi:10.1001/jama.2016.20619

This Viewpoint discusses step therapy as a means of controlling prescription drug costs, different categories of step therapy, and the challenges of using this approach to ensure quality and affordability of prescribing.

February 2, 2017
Viewpoint

Improving the Health of the United States With a “Winnable Battles” Initiative

Abstract Full Text
free access
JAMA. Published online February 2, 2017. doi:10.1001/jama.2017.0436

In this Viewpoint, former Centers for Disease Control and Prevention Director Thomas Frieden and colleagues review the Center’s 2010 Winnable Battles initiative, and discuss target areas where they met and fell short of their public health goals.

×